Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sk Shahriar Ahmed

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cureus|March 17, 2025
Intra-Class Interleukin-(IL)-17 Blocker Switching: Ixekizumab as a Solution for Secukinumab Non-responders in Secondary Biologic Failure in PsoriasisAbhishek De, Disha Chakraborty, Sk Shahriar Ahmed
Indian Journal of Dermatology|August 2, 2023
Biologics and Biosimilars in PsoriasisSk Shahriar Ahmed, Abhishek De, Sudip Das, et al.
Cureus|March 28, 2025
Baricitinib in the Treatment of Severe Atopic Dermatitis Resistant to Cyclosporine: A Case Report Involving Two CasesAbhishek De, Sk Shahriar Ahmed, Disha Chakraborty, et al.
Indian Journal of Dermatology|November 17, 2022
Porokeratosis and Lichen Planus: Co-Localisation or Isotopic Response or Koebner's Phenomenon?Jayanti Datta, Sk Shahriar Ahmed, Sudipta Roy, et al.
Indian Journal of Dermatology|October 12, 2023
Topical Therapy in PsoriasisSk Shahriar Ahmed, Yashpal Manchanda, Abhishek De, et al.
Indian Journal of Dermatology|January 24, 2022
An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic UrticariaAmrita Sil, Sufiur Rahaman, Nasiruddin Mondal, et al.
Indian Journal of Dermatology, Venereology and Leprology|December 3, 2022
Authors' replyAparesh Chandra Patra, Amrita Sil, Sk Shahriar Ahmed, et al.
Indian Journal of Dermatology, Venereology and Leprology|October 21, 2021
Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomized, double-blind and placebo-controlled studyAparesh Chandra Patra, Amrita Sil, Sk Shahriar Ahmed, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cureus|March 17, 2025
Intra-Class Interleukin-(IL)-17 Blocker Switching: Ixekizumab as a Solution for Secukinumab Non-responders in Secondary Biologic Failure in PsoriasisAbhishek De, Disha Chakraborty, Sk Shahriar Ahmed
Indian Journal of Dermatology|August 2, 2023
Biologics and Biosimilars in PsoriasisSk Shahriar Ahmed, Abhishek De, Sudip Das, et al.
Cureus|March 28, 2025
Baricitinib in the Treatment of Severe Atopic Dermatitis Resistant to Cyclosporine: A Case Report Involving Two CasesAbhishek De, Sk Shahriar Ahmed, Disha Chakraborty, et al.
Indian Journal of Dermatology|November 17, 2022
Porokeratosis and Lichen Planus: Co-Localisation or Isotopic Response or Koebner's Phenomenon?Jayanti Datta, Sk Shahriar Ahmed, Sudipta Roy, et al.
Indian Journal of Dermatology|October 12, 2023
Topical Therapy in PsoriasisSk Shahriar Ahmed, Yashpal Manchanda, Abhishek De, et al.
Indian Journal of Dermatology|January 24, 2022
An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic UrticariaAmrita Sil, Sufiur Rahaman, Nasiruddin Mondal, et al.
Indian Journal of Dermatology, Venereology and Leprology|December 3, 2022
Authors' replyAparesh Chandra Patra, Amrita Sil, Sk Shahriar Ahmed, et al.
Indian Journal of Dermatology, Venereology and Leprology|October 21, 2021
Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomized, double-blind and placebo-controlled studyAparesh Chandra Patra, Amrita Sil, Sk Shahriar Ahmed, et al.
Pageof 1